Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older
Clinical trial NCT05373485 · COMPLETED
Trial details
- NCT number
- NCT05373485
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2022-08-08
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.